Vaccinations of U.S. children declined after publication of a now-refuted autism risk: study

June 4, 2012 By Judy Ashton
Vaccinations of U.S. children declined after publication of a now-refuted autism risk
UC researcher Lenisa Chang

(Medical Xpress) -- New University of Cincinnati research has found that fewer parents in the United States vaccinated their children in the wake of concerns about a purported link (now widely discredited) between the MMR (measles, mumps, rubella) vaccine and autism.
 
Lenisa Chang, assistant professor of economics in UC’s Carl H. Lindner College of Business, found that the MMR-autism controversy, which played out prominently in the popular media following publication in a 1998 medical journal, led to a decline of about two percentage points in terms of parents obtaining the MMR vaccine for their children in 1999 and 2000. And even after later studies thoroughly refuted the alleged MMR-autism link, the drop off in vaccination rates persisted.

For her study, “The MMR-Autism Controversy: Did Concerns Affect Vaccine Take Up?” to be presented during the 4th Biennial Conference of the American Society of Health Economics June 10-13 in Minnesota, Chang examined data from the National Immunization Survey from 1995 through 2006 to gauge ’ response toward the vaccine-autism controversy.
 
Interestingly, in the aftermath of the controversy, Chang found that the higher a mother’s education level, the less likely a child was to receive an MMR vaccination. In other words, college-educated mothers were less likely to have their children vaccinated than were non-college education mothers. This may be due to the fact that more educated mothers have better access and/or more quickly absorb medical information available in the media.

After epidemiological studies refuted the MMR-autism link, the difference in MMR usage by mother’s education level persisted and became more pronounced in 2003, 2004 and 2006, possibly as previous negative information received more weight than positive information in the parental decision-making process on whether or not to vaccinate.

She also found that the controversy, begun with the publication of research (later discredited) linking the MMR vaccine to risks for autism in “The Lancet” medical journal, seemingly had a spillover effect to other vaccines—such as polio or other measles-containing vaccines—likely as a result of concern for safety over the MMR controversy.
 
Chang says the decline is a significant decrease and attributes the spillover effect to parental concerns.
 
“The I find on other vaccines such as polio and, to a lesser degree DTP (diphtheria, tetanus and pertussis), could be partially ascribed to general safety concerns toward all vaccines that stemmed from the MMR controversy, but other factors might be at play as well,” Chang says.
 
In other related work, Chang is researching the effect on immunization rates of state mandates that require insurance companies to cover childhood vaccines.  

Explore further: Mayo Clinic physician: Mistaken fear of measles shot has 'devastating' effect

Related Stories

Mayo Clinic physician: Mistaken fear of measles shot has 'devastating' effect

August 30, 2011
More than 150 cases of measles have been reported in the United States already this year and there have been similar outbreaks in Europe, a sign the disease is making an alarming comeback. The reappearance of the potentially ...

Recommended for you

With no morphine, 25 million die in pain each year: report

October 13, 2017
Every year, some 25 million people—one in ten of them children—die in serious pain that could have been alleviated with morphine at just a few cents per dose, researchers said Friday.

Study finds few restrictions on Rx opioids through Medicare

October 9, 2017
Medicare plans place few restrictions on the coverage of prescription opioids, despite federal guidelines recommending such restrictions, a new Yale study finds. The research results highlight an untapped opportunity for ...

Nocebo effect: Does a drug's high price tag cause its own side effects?

October 5, 2017
Pricey drugs may make people more vulnerable to perceiving side effects, a new study suggests—and the phenomenon is not just "in their heads."

Pre-packaged brand version of compounded medication to prevent preterm births costs 5,000 percent more

October 2, 2017
Preventing a preterm birth could cost as little as $200 or as much as $20,000, depending on which one of two medications a doctor orders, according to a new analysis from Harvard Medical School.

Cancer drugs' high prices not justified by cost of development, study contends

September 12, 2017
(HealthDay)— Excusing the sky-high price tags of many new cancer treatments, pharmaceutical companies often blame high research and development (R&D) costs.

Non-psychotropic cannabinoids show promise for pain relief

September 4, 2017
Some cancers love bone. They thrive in its nutrient-rich environment while gnawing away at the very substrate that sustains them, all the while releasing inflammatory substances that cause pain—pain so severe that opioids ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.